These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10026829)

  • 1. Mutations in the vasopressin V2 receptor and aquaporin-2 genes in twelve families with congenital nephrogenic diabetes insipidus.
    Vargas-Poussou R; Forestier L; Dautzenberg MD; Niaudet P; Déchaux M; Antignac C
    Adv Exp Med Biol; 1998; 449():387-90. PubMed ID: 10026829
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus.
    Vargas-Poussou R; Forestier L; Dautzenberg MD; Niaudet P; Déchaux M; Antignac C
    J Am Soc Nephrol; 1997 Dec; 8(12):1855-62. PubMed ID: 9402087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analyses of the vasopressin type 2 receptor and aquaporin-2 genes in Brazilian kindreds with nephrogenic diabetes insipidus.
    Rocha JL; Friedman E; Boson W; Moreira A; Figueiredo B; Liberman B; de Lacerda L; Sandrini R; Graf H; Martins S; Puñales MK; De Marco L
    Hum Mutat; 1999; 14(3):233-9. PubMed ID: 10477431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nephrogenic diabetes insipidus associated with mutations of vasopressin V2 receptors and aquaporin-2].
    Ishikawa SE
    Nihon Rinsho; 2002 Feb; 60(2):350-5. PubMed ID: 11857925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two novel mutations in the aquaporin-2 and the vasopressin V2 receptor genes in patients with congenital nephrogenic diabetes insipidus.
    Oksche A; Möller A; Dickson J; Rosendahl W; Rascher W; Bichet DG; Rosenthal W
    Hum Genet; 1996 Nov; 98(5):587-9. PubMed ID: 8882880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin type-2 receptor and aquaporin-2 water channel mutants in nephrogenic diabetes insipidus.
    Deen PM; Knoers NV
    Am J Med Sci; 1998 Nov; 316(5):300-9. PubMed ID: 9822112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [From genes to disease: from vasopressin-V2-receptor and aquaporine-2 to nephrogenic diabetes insipidus].
    Knoers NV; Deen PM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2402-4. PubMed ID: 11145096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrogenic diabetes insipidus.
    Deen PM; Marr N; Kamsteeg EJ; van Balkom BW
    Curr Opin Nephrol Hypertens; 2000 Nov; 9(6):591-5. PubMed ID: 11128419
    [No Abstract]   [Full Text] [Related]  

  • 9. Aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus.
    van Os CH; Deen PM
    Proc Assoc Am Physicians; 1998; 110(5):395-400. PubMed ID: 9756089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathogenesis of nephrogenic diabetes insipidus.
    Nguyen MK; Nielsen S; Kurtz I
    Clin Exp Nephrol; 2003 Mar; 7(1):9-17. PubMed ID: 14586738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation affecting the arginine-137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin-2.
    Hinrichs GR; Hansen LH; Nielsen MR; Fagerberg C; Dieperink H; Rittig S; Jensen BL
    Physiol Rep; 2016 Apr; 4(8):. PubMed ID: 27117808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families.
    Pasel K; Schulz A; Timmermann K; Linnemann K; Hoeltzenbein M; Jääskeläinen J; Grüters A; Filler G; Schöneberg T
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1703-10. PubMed ID: 10770218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and cellular defects in nephrogenic diabetes insipidus.
    Knoers NV; van Os CH
    Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):353-8. PubMed ID: 8823534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe bladder dysfunction in a family with ADH receptor gene mutation responsible for X-linked nephrogenic diabetes insipidus.
    Ulinski T; Grapin C; Forin V; Vargas-Poussou R; Deschênes G; Bensman A
    Nephrol Dial Transplant; 2004 Nov; 19(11):2928-9. PubMed ID: 15496575
    [No Abstract]   [Full Text] [Related]  

  • 15. Nephrogenic diabetes insipidus: update of genetic and clinical aspects.
    Sasaki S
    Nephrol Dial Transplant; 2004 Jun; 19(6):1351-3. PubMed ID: 15004257
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary content of aquaporin 1 and 2 in nephrogenic diabetes insipidus.
    Deen PM; van Aubel RA; van Lieburg AF; van Os CH
    J Am Soc Nephrol; 1996 Jun; 7(6):836-41. PubMed ID: 8793791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nephrogenic diabetes insipidus].
    Evrard A; Lefebvre J; Vantyghem M
    Ann Endocrinol (Paris); 1999 Dec; 60(6):457-64. PubMed ID: 10617799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vasopressin V2 receptor-related pathologies: congenital nephrogenic diabetes insipidus and nephrogenic syndrome of inappropiate antidiuresis].
    Morin D
    Nephrol Ther; 2014 Dec; 10(7):538-46. PubMed ID: 25449762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aquaporin-2 water channel mutations and nephrogenic diabetes insipidus: new variations on a theme.
    Rutishauser J; Kopp P
    Eur J Endocrinol; 1999 Feb; 140(2):137-9. PubMed ID: 10069656
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between AVPR2 mutations and urinary AQP2 excretion in patients with nephrogenic diabetes insipidus.
    Kotnik P; Battelino T; Debeljak M; Podkrajsek KT; Waldhauser F; Frøkiaer J; Nielsen S; Krzisnik C
    J Pediatr Endocrinol Metab; 2007 Apr; 20(4):483-9. PubMed ID: 17550212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.